Dana E. Rathkopf, MD

Dana E. Rathkopf, MD

I am a board-certified medical oncologist who works as part of a multidisciplinary team to treat patients with prostate cancer and other genitourinary malignancies. My primary focus is on the medical treatment of men with advanced or high-risk prostate cancer. In addition to using standard therapies, I develop and design clinical trials testing new agents directed at androgen receptor signaling and other molecular pathways of disease progression.

On a national level, I am the site Principal Investigator at MSK for the Department of Defense Prostate Cancer Clinical Trials Consortium (PCCTC), an initiative designed to increase patient access to clinical trials across the country.  I am also an expert panel member on the American Society of Clinical Oncology (ASCO) Clinical Guidelines Committee and serve as co-chair of the ASCO Genitourinary Guidelines Advisory Group.

Appointments for New Patients
Clinical Expertise

Prostate Cancer; Other Genitourinary Cancers; Clinical Trials

Languages Spoken

MD, Tulane School of Medicine


New York University Medical Center


Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology

Publications by Dana E. Rathkopf
Visit PubMed for full listing of Dana E. Rathkopf journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.